ProShare Advisors’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $505K | Sell |
3,914
-926
| -19% | -$133K | ﹤0.01% | 1058 |
|
|
2025
Q4 | $691K | Buy |
4,840
+141
| +3% | +$18.9K | ﹤0.01% | 967 |
|
|
2025
Q3 | $564K | Sell |
4,699
-862
| -16% | -$109K | ﹤0.01% | 1044 |
|
|
2025
Q2 | $735K | Buy |
5,561
+361
| +7% | +$48.9K | ﹤0.01% | 928 |
|
|
2025
Q1 | $722K | Sell |
5,200
-1,413
| -21% | -$219K | ﹤0.01% | 921 |
|
|
2024
Q4 | $1.03M | Buy |
6,613
+2,081
| +46% | +$352K | ﹤0.01% | 899 |
|
|
2024
Q3 | $826K | Buy |
+4,532
| New | +$671K | ﹤0.01% | 867 |
|
|
2023
Q3 | – | Sell |
-1,228
| Closed | -$219K | – | 1840 |
|
|
2023
Q2 | $219K | Sell |
1,228
-101
| -8% | -$18.5K | ﹤0.01% | 1481 |
|
|
2023
Q1 | $219K | Sell |
1,329
-218
| -14% | -$37.5K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $244K | Buy |
1,547
+132
| +9% | +$20.1K | ﹤0.01% | 1361 |
|
|
2022
Q3 | $213K | Sell |
1,415
-17
| -1% | -$2.83K | ﹤0.01% | 1366 |
|
|
2022
Q2 | $235K | Sell |
1,432
-554
| -28% | -$107K | ﹤0.01% | 1368 |
|
|
2022
Q1 | $442K | Sell |
1,986
-316
| -14% | -$70.8K | ﹤0.01% | 1357 |
|
|
2021
Q4 | $546K | Buy |
2,302
+452
| +24% | +$106K | ﹤0.01% | 1382 |
|
|
2021
Q3 | $432K | Sell |
1,850
-354
| -16% | -$74.2K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $454K | Buy |
2,204
+323
| +17% | +$66.4K | ﹤0.01% | 1600 |
|
|
2021
Q1 | $386K | Buy |
1,881
+2
| +0.1% | +$422 | ﹤0.01% | 1632 |
|
|
2020
Q4 | $403K | Buy |
1,879
+228
| +14% | +$44.2K | ﹤0.01% | 1407 |
|
|
2020
Q3 | $302K | Buy |
1,651
+59
| +4% | +$11.1K | ﹤0.01% | 1170 |
|
|
2020
Q2 | $293K | Buy |
1,592
+530
| +50% | +$105K | ﹤0.01% | 1242 |
|
|
2020
Q1 | $214K | Sell |
1,062
-1,026
| -49% | -$197K | ﹤0.01% | 987 |
|
|
2019
Q4 | $391K | Buy |
2,088
+191
| +10% | +$32.9K | ﹤0.01% | 1198 |
|
|
2019
Q3 | $303K | Buy |
1,897
+165
| +10% | +$32.8K | ﹤0.01% | 1228 |
|
|
2019
Q2 | $436K | Sell |
1,732
-331
| -16% | -$76.7K | ﹤0.01% | 1066 |
|
|
2019
Q1 | $494K | Buy |
2,063
+474
| +30% | +$114K | ﹤0.01% | 1024 |
|
|
2018
Q4 | $365K | Sell |
1,589
-365
| -19% | -$90K | ﹤0.01% | 1053 |
|
|
2018
Q3 | $552K | Buy |
1,954
+657
| +51% | +$192K | ﹤0.01% | 1060 |
|
|
2018
Q2 | $381K | Sell |
1,297
-1,933
| -60% | -$528K | ﹤0.01% | 1244 |
|
|
2018
Q1 | $815K | Buy |
3,230
+537
| +20% | +$126K | 0.01% | 911 |
|
|
2017
Q4 | $582K | Buy |
2,693
+1,367
| +103% | +$277K | ﹤0.01% | 1054 |
|
|
2017
Q3 | $246K | Sell |
1,326
-227
| -15% | -$39.6K | ﹤0.01% | 1210 |
|
|
2017
Q2 | $268K | Sell |
1,553
-486
| -24% | -$78K | ﹤0.01% | 1224 |
|
|
2017
Q1 | $311K | Sell |
2,039
-651
| -24% | -$95.1K | ﹤0.01% | 1227 |
|
|
2016
Q4 | $396K | Buy |
2,690
+951
| +55% | +$138K | ﹤0.01% | 1206 |
|
|
2016
Q3 | $220K | Sell |
1,739
-385
| -18% | -$46.4K | ﹤0.01% | 1304 |
|
|
2016
Q2 | $239K | Buy |
2,124
+62
| +3% | +$6.43K | ﹤0.01% | 1323 |
|
|
2016
Q1 | $215K | Sell |
2,062
-353
| -15% | -$33.8K | ﹤0.01% | 1379 |
|
|
2015
Q4 | $272K | Buy |
+2,415
| New | +$267K | ﹤0.01% | 1342 |
|
|
2015
Q2 | – | Sell |
-2,963
| Closed | -$276K | – | 1713 |
|
|
2015
Q1 | $276K | Sell |
2,963
-208
| -7% | -$18.2K | ﹤0.01% | 1516 |
|
|
2014
Q4 | $260K | Sell |
3,171
-2,446
| -44% | -$188K | ﹤0.01% | 1613 |
|
|
2014
Q3 | $360K | Sell |
5,617
-1,385
| -20% | -$84.8K | ﹤0.01% | 1595 |
|
|
2014
Q2 | $426K | Sell |
7,002
-6,409
| -48% | -$378K | 0.01% | 1682 |
|
|
2014
Q1 | $803K | Buy |
+13,411
| New | +$826K | 0.01% | 1477 |
|
|
2013
Q4 | – | Sell |
-8,466
| Closed | -$575K | – | 1590 |
|
|
2013
Q3 | $575K | Sell |
8,466
-178
| -2% | -$12.7K | 0.01% | 1343 |
|
|
2013
Q2 | $623K | Buy |
+8,644
| New | +$572K | 0.01% | 1158 |
|
Other funds holding ICUI
VPM
VCM
RRAM
ProShare Advisors's ICUI Position: Q1 2026 in Review
ProShare Advisors reduced its ICU Medical (ICUI) stake by 19% in Q1 2026, selling an estimated $133K and leaving 3,914 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.
ProShare Advisors first reported a position in ICUI in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.03M in Q4 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- ProShare Advisors held 3,914 shares of ICU Medical worth $505K as of Q1 2026.
- ProShare Advisors sold 926 ICU Medical shares in Q1 2026, an estimated $133K.
- ICU Medical made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1058 holding.
- ProShare Advisors first reported a position in ICU Medical in Q2 2013 and has held it in 45 quarters since.
- ProShare Advisors's ICU Medical position peaked at $1.03M in Q4 2024.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.